Organization · Grant Maker
Target ALS
Target ALS is a nonprofit organization based in New York City, dedicated to accelerating ALS research and treatment discovery through collaborative initiatives and funding.
Overview
What Target ALS does
What Target ALS is
Target ALS is a nonprofit organization based in New York City, dedicated to accelerating ALS research and treatment discovery through collaborative initiatives and funding.
How it participates in the startup ecosystem
The current public profile supports grantor and event host and publisher capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Grant Maker
- Founded
- Founded in 2013
- Approximate age
- About 13 years
- Structured capabilities
- Grantor · Event host · Publisher
- Last reviewed
- March 19, 2026
Official channels
Find Target ALS elsewhere
Open the official website or a supported primary organization account.
Capability profile
Target ALS as a grantor
Grant thesis
Target ALS is dedicated to breaking down barriers to research in the fight against amyotrophic lateral sclerosis (ALS) and aims to accelerate the discovery of effective treatments through its Innovation Ecosystem.
Focus narrative
Target ALS invests in ALS research across various domains, including understanding ALS biology, accelerating drug discovery, and developing biomarkers for earlier diagnosis. The organization supports collaborative projects and individual investigator grants, fostering partnerships between academia and industry to enhance research efforts.
Value and support
Beyond funding, Target ALS fosters partnerships between academia and industry, enhancing research efforts and facilitating collaborations that can lead to significant advancements in ALS treatments.
Grant economics
- Dilutive
- No
- Nonprofit only
- Yes
Eligibility and fit
- Stages
- Pre-seed · Seed
- Audience
- Researchers
- Regions
- United States
Process and recipient context
Application process
Target ALS has a structured application process for its grants, focusing on collaborative projects and individual investigator grants. Researchers can apply for funding through their website, where they can find detailed information about the application requirements and guidelines.
Recipient context
Target ALS has funded over 750 research grants, investing more than $80 million in ALS research. Approximately 58% of the funded projects have led to drug discovery programs, showcasing the impact of their funding on advancing ALS research.
Capability profile
Target ALS as an event host
Event focus
Target ALS invests in ALS research across various domains, including understanding ALS biology, accelerating drug discovery, and developing biomarkers for earlier diagnosis. The organization supports collaborative projects and individual investigator grants, fostering partnerships between academia and industry to enhance research efforts.
Format narrative
Target ALS hosts an annual meeting each spring, gathering researchers, industry leaders, and advocates to discuss the latest breakthroughs in ALS research and foster collaborations.
Participant value
Attendees gain insights into the latest research breakthroughs in ALS, opportunities for collaboration, and access to a network of professionals dedicated to fighting ALS.
Format and cadence
- Event types
- conference
- Recurrence
- annual
- Modality
- in-person
- Startups can present
- No
Availability
- Registration state
- Not currently accepting
Audience and fit
- Audience
- Researchers · Founders
- Sectors
- Healthcare
- Regions
- United States
Speakers and past editions
Speakers
Notable speakers include researchers, industry leaders, and advocates in the field of ALS.
Past editions
The annual meeting has successfully gathered key stakeholders in ALS research to discuss advancements and collaborations.
Capability profile
Target ALS as a publisher
Editorial focus
Target ALS is dedicated to breaking down barriers to research in the fight against amyotrophic lateral sclerosis (ALS). The organization aims to accelerate the discovery of effective treatments through its Innovation Ecosystem, investing in various domains of ALS research, including biology, drug discovery, and biomarker development.
Audience value
Target ALS provides critical funding and support for ALS research, fostering collaborations between academia and industry to enhance research efforts and accelerate drug discovery.
Format and cadence
- Content formats
- newsletter, blog, and webinar-series
- Primary platform
- Website
Availability
- Guest pitch state
- Not currently accepting
Audience and focus
- Audience
- Researchers
- Sectors
- Healthcare
- Regions
- North America
Flagship work and coverage
Flagship properties
Target ALS publishes newsletters and articles on their website, and hosts webinars and events to engage the community and share research updates.
Common questions
What to know about Target ALS
Upseed classifies Target ALS under the Grant Maker organization type. Its current public profile includes grantor, event host, and publisher capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 19, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.